Beximco Pharmaceuticals Limited
Beximco Pharmaceuticals Limited, often referred to as Beximco Pharma, is a leading player in the pharmaceutical industry, headquartered in Dhaka, Bangladesh (BD). Established in 1976, the company has made significant strides in the production of high-quality generic medicines, active pharmaceutical ingredients (APIs), and over-the-counter products, catering to both domestic and international markets. With a strong focus on research and development, Beximco Pharma has developed a diverse portfolio that includes formulations across various therapeutic areas, such as cardiology, oncology, and anti-infectives. The company is renowned for its commitment to quality and innovation, which has positioned it as a trusted name in the global pharmaceutical landscape. Notable achievements include regulatory approvals from prestigious agencies, underscoring its reputation for excellence and reliability in healthcare solutions.
DitchCarbon Score
How does Beximco Pharmaceuticals Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Beximco Pharmaceuticals Limited's score of 10 is lower than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Beximco Pharmaceuticals Limited's reported carbon emissions
Beximco Pharmaceuticals Limited, headquartered in BD, currently does not have publicly available carbon emissions data for the most recent year, nor specific reduction targets or climate commitments outlined in their initiatives. Without concrete figures or defined goals, it is challenging to assess their carbon footprint or climate strategy. However, the pharmaceutical industry is increasingly focusing on sustainability and reducing greenhouse gas emissions, indicating a potential commitment to future climate action. As the industry evolves, Beximco Pharmaceuticals may align with these trends to enhance their environmental responsibility.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Beximco Pharmaceuticals Limited is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
